Cocrystal Pharma (COCP) Deferred Taxes (2011 - 2018)
Cocrystal Pharma (COCP) posted Deferred Taxes of $12.1 million for Q4 2018, up 2394.44% sequentially from $486000.0 in Q3 2018, and up 75.85% YoY from $6.9 million in Q4 2017.
Cocrystal Pharma (COCP) Deferred Taxes (2011 - 2018) Analysis & Trends
Cocrystal Pharma has reported Deferred Taxes for 5 years, with the latest figure at $12.1 million in Q4 2018.
- Quarterly Deferred Taxes rose 75.85% year-over-year to $12.1 million in Q4 2018, while the trailing twelve-month figure through Dec 2018 was $13.6 million (down 62.58% YoY) and the FY2018 annual result came in at $13.6 million, up 97.41% from the prior year.
- Deferred Taxes advanced to $12.1 million in Q4 2018 per COCP's latest filing, from $486000.0 in the prior quarter.
- Over five years, Deferred Taxes peaked at $29.4 million in Q4 2016 and troughed at -$16000.0 in Q1 2017.
- A 4-year average of $7.2 million and a median of $554000.0 in 2018 frame the typical range for Deferred Taxes.
- The sharpest annual moves came in 2017 and 2018: Deferred Taxes sank 700.0% in 2017, then surged 2718.75% in 2018.
- Over 4 years, Deferred Taxes stood at $15.2 million in 2015, then jumped by 93.36% to $29.4 million in 2016, then tumbled by 76.57% to $6.9 million in 2017, then surged by 75.85% to $12.1 million in 2018.
- According to Business Quant data, Deferred Taxes over the past three periods registered $12.1 million, $486000.0, and $554000.0 for Q4 2018, Q3 2018, and Q2 2018 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -69.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 194.40 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 2.66 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Cocrystal Pharma | 15.65 Mn | 13.33 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 12.12 Mn |
| Sep 30, 2018 | 486,000.00 |
| Jun 30, 2018 | 554,000.00 |
| Mar 31, 2018 | 419,000.00 |
| Dec 31, 2017 | 6.89 Mn |
| Mar 31, 2017 | -16,000.00 |
| Dec 31, 2016 | 29.42 Mn |
| Mar 31, 2016 | -2,000.00 |
| Dec 31, 2015 | 15.22 Mn |
| Mar 31, 2011 | 7,060.00 |